MedTrace Logo

Dietary Supplement With and Without a Probiotic

NCT04433208 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 62

Last updated 2025-03-18

Study results available
· View outcomes & findings →

Summary

Complex oligosaccharides can alter the gut microbiome by aiding in the growth of certain organisms, and possibly, inhibiting others. The synergy with a probiotic may enhance gastrointestinal colonization.

Conditions

  • Healthy Adult Subjects

Interventions

DIETARY_SUPPLEMENT

Complex oligosaccharide

Complex oligosaccharide concentrate

DIETARY_SUPPLEMENT

Probiotic

Probiotic

OTHER

PPI

Over-the-counter proton pump inhibitor (PPI)

OTHER

H2 Blocker

Over-the-counter H2 blocker

Sponsors & Collaborators

  • Prolacta Bioscience

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
44 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-03-13
Primary Completion
2020-12-02
Completion
2020-12-02

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04433208 on ClinicalTrials.gov